368 related articles for article (PubMed ID: 19088199)
1. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.
Orabona C; Pallotta MT; Volpi C; Fallarino F; Vacca C; Bianchi R; Belladonna ML; Fioretti MC; Grohmann U; Puccetti P
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20828-33. PubMed ID: 19088199
[TBL] [Abstract][Full Text] [Related]
2. Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3).
Pallotta MT; Orabona C; Volpi C; Grohmann U; Puccetti P; Fallarino F
Int J Tryptophan Res; 2010; 3():91-7. PubMed ID: 22084591
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant.
Orabona C; Belladonna ML; Vacca C; Bianchi R; Fallarino F; Volpi C; Gizzi S; Fioretti MC; Grohmann U; Puccetti P
J Immunol; 2005 Jun; 174(11):6582-6. PubMed ID: 15905495
[TBL] [Abstract][Full Text] [Related]
4. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells.
Fallarino F; Orabona C; Vacca C; Bianchi R; Gizzi S; Asselin-Paturel C; Fioretti MC; Trinchieri G; Grohmann U; Puccetti P
Int Immunol; 2005 Nov; 17(11):1429-38. PubMed ID: 16172135
[TBL] [Abstract][Full Text] [Related]
5. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
Munn DH; Sharma MD; Mellor AL
J Immunol; 2004 Apr; 172(7):4100-10. PubMed ID: 15034022
[TBL] [Abstract][Full Text] [Related]
6. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.
Koorella C; Nair JR; Murray ME; Carlson LM; Watkins SK; Lee KP
J Biol Chem; 2014 Mar; 289(11):7747-62. PubMed ID: 24415757
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1.
Albini E; Rosini V; Gargaro M; Mondanelli G; Belladonna ML; Pallotta MT; Volpi C; Fallarino F; Macchiarulo A; Antognelli C; Bianchi R; Vacca C; Puccetti P; Grohmann U; Orabona C
J Cell Mol Med; 2017 Jan; 21(1):165-176. PubMed ID: 27696702
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy.
Maazi H; Shirinbak S; den Boef LE; Fallarino F; Volpi C; Nawijn MC; van Oosterhout AJ
Clin Exp Immunol; 2013 Apr; 172(1):113-20. PubMed ID: 23480191
[TBL] [Abstract][Full Text] [Related]
10. Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.
Colvin BL; Sumpter TL; Tokita D; Salati J; Mellor AL; Thomson AW
Hum Immunol; 2009 May; 70(5):313-20. PubMed ID: 19208362
[TBL] [Abstract][Full Text] [Related]
11. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
[TBL] [Abstract][Full Text] [Related]
12. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.
Qureshi OS; Zheng Y; Nakamura K; Attridge K; Manzotti C; Schmidt EM; Baker J; Jeffery LE; Kaur S; Briggs Z; Hou TZ; Futter CE; Anderson G; Walker LS; Sansom DM
Science; 2011 Apr; 332(6029):600-3. PubMed ID: 21474713
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice.
Misaki K; Morinobu A; Saegusa J; Kasagi S; Fujita M; Miyamoto Y; Matsuki F; Kumagai S
Arthritis Res Ther; 2011 May; 13(3):R77. PubMed ID: 21592365
[TBL] [Abstract][Full Text] [Related]
15. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
[TBL] [Abstract][Full Text] [Related]
16. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO.
Belladonna ML; Grohmann U; Guidetti P; Volpi C; Bianchi R; Fioretti MC; Schwarcz R; Fallarino F; Puccetti P
J Immunol; 2006 Jul; 177(1):130-7. PubMed ID: 16785507
[TBL] [Abstract][Full Text] [Related]
17. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells.
Belladonna ML; Volpi C; Bianchi R; Vacca C; Orabona C; Pallotta MT; Boon L; Gizzi S; Fioretti MC; Grohmann U; Puccetti P
J Immunol; 2008 Oct; 181(8):5194-8. PubMed ID: 18832670
[TBL] [Abstract][Full Text] [Related]
19. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating Factor Mediates Endotoxin Tolerance by Regulating Indoleamine 2,3-Dioxygenase-dependent Expression of the Suppressor of Cytokine Signaling 3.
Noh KT; Jung ID; Cha GS; Han MK; Park YM
J Biol Chem; 2017 Feb; 292(8):3290-3298. PubMed ID: 28077574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]